The Government’s announcement of £300m funding to support the sequencing of the genetic codes of 100,000 people in England has been welcomed by head of MedCity Dr Eliot Forster
The project, led by Genomics England, will initially focus on rare diseases, cancer and infectious disease, and will support the development of targeted, personalised therapies. Eliot says:
“The UK’s commitment to science means that more and more we are home to the sort of major longitudinal research studies that simply aren’t being done elsewhere. The 100,000 genomes project, with its emphasis on developing targeted, personalised therapies, has the potential to be transformative for our health and well-being, and provide a patient data set that will be the envy of the world.
“Adding to our other strengths in life sciences, including world-class research universities and a health service that gives access to a huge, diverse patient population, this initiative will be a massive incentive for international investment in the UK’s medical research and development base.”